We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+33.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$22.8M
Cap. Flow
+$4.67M
Cap. Flow %
1.71%
Top 10 Hldgs %
26.58%
Holding
166
New
40
Increased
8
Reduced
21
Closed
31

Top Buys

Rank Stock Value
1
BLRX
BioLineRX
BLRX
+$5.92M
2
PLRX icon
Pliant Therapeutics
PLRX
+$4.11M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$3.89M
4
RMD icon
ResMed
RMD
+$3.87M
5
BCAB icon
BioAtla
BCAB
+$3.62M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$5.32M
2
LNTH icon
Lantheus
LNTH
+$3.48M
3
ESPR
Esperion Therapeutics
ESPR
+$3.45M
4
DXCM icon
DexCom
DXCM
+$3.28M
5
LIVN icon
LivaNova
LIVN
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 79.05%
2 Financials 10.08%
3 Industrials 0.61%
4 Consumer Staples 0.24%
5 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHAAW
126
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$5K ﹤0.01%
50,000
– –
EUCRW
127
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$5K ﹤0.01%
133,333
– –
ADRT.WS
128
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$5K ﹤0.01%
112,500
– –
GIWWW
129
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$3K ﹤0.01%
50,000
– –
PSQH.WS icon
130
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$2K ﹤0.01%
16,666
– –
MITAW
131
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$2K ﹤0.01%
28,333
– –
AXH.WS
132
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$2K ﹤0.01%
100,000
– –
SRSAW
133
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$2K ﹤0.01%
75,000
– –
TMPMW
134
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$2K ﹤0.01%
84,666
– –
AGIO icon
135
Agios Pharmaceuticals
AGIO
$1.93B
– –
-73,000
Closed -$1.62M
ALT icon
136
Altimmune
ALT
$599M
– –
-98,659
Closed -$1.15M
LONA
137
CALL
LeonaBio Inc
LONA
$72.1M
– –
-20,010
Closed -$610K
AXSM icon
138
PUT
Axsome Therapeutics
AXSM
$10.9B
– –
-50,000
Closed -$1.92M
BBIO icon
139
CALL
BridgeBio Pharma
BBIO
$16.5B
– –
-17,400
Closed -$158K
BURU
140
DELISTED
NUBURU INC
BURU
– –
-643
Closed -$1.28M
DXCM icon
141
DexCom
DXCM
$32B
– –
-44,000
Closed -$3.28M
GERN icon
142
Geron
GERN
$949M
– –
-371,367
Closed -$576K
HLLY icon
143
Holley
HLLY
$384M
– –
-80,000
Closed -$840K
HRMY icon
144
Harmony Biosciences
HRMY
$2.24B
– –
-50,000
Closed -$2.44M
IMTXW
145
DELISTED
Immatics N.V. Warrants
IMTXW
– –
-97,467
Closed -$199K
KURA icon
146
Kura Oncology
KURA
$850M
– –
-147,000
Closed -$2.69M
LIVN icon
147
LivaNova
LIVN
$4.2B
– –
-50,000
Closed -$3.12M
MASS icon
148
908 Devices
MASS
$364M
– –
-125,000
Closed -$2.57M
MOBX icon
149
Mobix Labs
MOBX
$26M
– –
-20,000
Closed -$2M
OM icon
150
Outset Medical
OM
$90.8M
– –
-6,925
Closed -$1.54M
3 4 5
6
7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Altium Capital Management held 166 positions worth $273M, up 9.1% from $250M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q3 2022 filing shows 40 new, 8 increased, 21 reduced and 31 closed positions. Its largest new stake was BioLineRX: 103,732 shares worth $3.84M. The largest sale was STAAR Surgical, an estimated $5.32M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 74% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q3 2022 buy was BioLineRX: 103,732 shares worth $3.84M.
  • Altium Capital Management added most to AngioDynamics in Q3 2022, an estimated $3.41M increase.
  • Altium Capital Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $3.48M.
  • Altium Capital Management fully exited STAAR Surgical in Q3 2022, selling an estimated $5.32M.
  • Altium Capital Management's ten largest holdings make up 27% of its $273M portfolio in Q3 2022.
  • Altium Capital Management opened 40 new positions and closed 31 in Q3 2022.
  • Altium Capital Management's portfolio value rose 9.1% quarter-over-quarter to $273M.

Based on Altium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.